Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway

Journal of Neurochemistry

Volumn 107, Issue 5, 2008, Pages 1284-1293

  Madziar, Beata ^a   Shah, Sonia ^a   Brock, Martina ^a   Burke, Rebecca ^a   Lopez Coviella, Ignacio ^a   Nickel, Ann Christin ^a   Cakal, Esra Betul ^a   Blusztajn, Jan Krzysztof ^a   Berse, Brygida ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Choline acetyltransferase; Choline transporter; PC12 cells; Protein kinase B; Septum

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEIN; CHOLINE ACETYLTRANSFERASE; CHOLINE TRANSPORTER; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC TRANSFECTION; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MEMBRANE TRANSPORT PROTEINS; MICE; NERVE GROWTH FACTOR; NEURONS; ONCOGENE PROTEIN V-AKT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, SMALL INTERFERING; SEPTUM OF BRAIN; SIGNAL TRANSDUCTION; TRANSFECTION;

RATTUS;

EID: 55849128946     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05681.x     Document Type: Article

References (52)

1. Agarwal A., Das K., Lerner N., Sathe S., Cicek M., Casey G. Sizemore N. (2005) The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24, 1021 1031.
2. Ahn J. Y., Rong R., Liu X. Ye K. (2004) PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J. 23, 3995 4006.
3. Apparsundaram S., Ferguson S. M. Blakely R. D. (2001) Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem. Soc. Trans. 29, 711 716.
4. Beaulieu J. M., Gainetdinov R. R. Caron M. G. (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166 172.
5. Berse B., Lopez-Coviella I. Blusztajn J. K. (1999) Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor. Biochem. J. 342, 301 308.
6. Berse B., Szczecinska W., Lopez-Coviella I., Madziar B., Zemelko V., Kaminski R., Kozar K., Lips K. S., Pfeil U. Blusztajn J. K. (2005) Expression of high affinity choline transporter during mouse development in vivo and its upregulation by NGF and BMP-4 in vitro. Brain Res. Dev. Brain Res. 157, 132 140.
7. Bijur G. N. Jope R. S. (2000) Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J. Neurochem. 75, 2401 2408.
8. Brandon E. P., Mellott T., Pizzo D. P. et al. (2004) Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J. Neurosci. 24, 5459 5466.
9. Brazil D. P., Yang Z. Z. Hemmings B. A. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233 242.
10. Brock M., Nickel A. C., Madziar B., Blusztajn J. K. Berse B. (2007) Differential regulation of the high affinity choline transporter and the cholinergic locus by cAMP signaling pathways. Brain Res. 1145, 1 10.
11. Brunet A., Datta S. R. Greenberg M. E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297 305.
12. Cantley L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655 1657.
13. Chan C. B. Ye K. (2007) PIKE GTPase are phosphoinositide-3-kinase enhancers, suppressing programmed cell death. J. Cell Mol. Med. 11, 39 53.
14. Cheng H. L., Steinway M., Delaney C. L., Franke T. F. Feldman E. L. (2000) IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol. Cell. Endocrinol. 170, 211 215.
15. Cole A. R., Astell A., Green C. Sutherland C. (2007) Molecular connexions between dementia and diabetes. Neurosci. Biobehav. Rev. 31, 1046 1063.
16. Downward J. (2004) PI 3-kinase, Akt and cell survival. Semin. Cell. Dev. Biol. 15, 177 182.
17. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R. Greenberg M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661 665.
18. Dunnett C. W. (1955) A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096 1121.
19. Ferguson S. M., Savchenko V., Apparsundaram S., Zwick M., Wright J., Heilman C. J., Yi H., Levey A. I. Blakely R. D. (2003) Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci. 23, 9697 9709.
20. Franke T. F. (2008) Intracellular signaling by Akt: bound to be specific. Sci. Signal. 1, pe29.
21. Fukunaga K., Ishigami T. Kawano T. (2005) Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons. J. Pharmacol. Sci. 98, 205 211.
22. Hanada M., Feng J. Hemmings B. A. (2004) Structure, regulation and function of PKB/AKT - a major therapeutic target. Biochim. Biophys. Acta 1697, 3 16.
23. Hiromura M., Okada F., Obata T., Auguin D., Shibata T., Roumestand C. Noguchi M. (2004) Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1. J. Biol. Chem. 279, 53407 53418.
24. Hresko R. C. Mueckler M. (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406 40416.
25. Hu Y., Qiao L., Wang S., Rong S. B., Meuillet E. J., Berggren M., Gallegos A., Powis G. Kozikowski A. P. (2000) 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J. Med. Chem. 43, 3045 3051.
26. Huang W. C. Chen C. C. (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 25, 6592 6602.
27. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S. Y., Huang Q., Qin J. Su B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125 137.
28. Kane L. P. Weiss A. (2003) The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192, 7 20.
29. Kaplan D. R. Miller F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381 391.
30. Kobayashi Y., Okuda T., Fujioka Y., Matsumura G., Nishimura Y. Haga T. (2002) Distribution of the high-affinity choline transporter in the human and macaque monkey spinal cord. Neurosci. Lett. 317, 25 28.
31. Kozikowski A. P., Sun H., Brognard J. Dennis P. A. (2003) Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. J. Am. Chem. Soc. 125, 1144 1145.
32. Kunstle G., Laine J., Pierron G., Kagami Si S., Nakajima H., Hoh F., Roumestand C., Stern M. H. Noguchi M. (2002) Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol. Cell. Biol. 22, 1513 1525.
33. Kus L., Borys E., Ping Chu Y., Ferguson S. M., Blakely R. D., Emborg M. E., Kordower J. H., Levey A. I. Mufson E. J. (2003) Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J. Comp. Neurol. 463, 341 357.
34. Lecomte M. J., De Gois S., Guerci A., Ravassard P., Faucon Biguet N., Mallet J. Berrard S. (2005) Differential expression and regulation of the high-affinity choline transporter CHT1 and choline acetyltransferase in neurons of superior cervical ganglia. Mol. Cell. Neurosci. 28, 303 313.
35. Lee S. R., Park J. H., Park E. K., Chung C. H., Kang S. S. Bang O. S. (2005) Akt-induced promotion of cell-cycle progression at G(2)/M phase involves upregulation of NF-Y binding activity in PC12 cells. J. Cell. Physiol. 205, 270 277.
36. Li Y., Holtzman D. M., Kromer L. F., Kaplan D. R., Chua-Couzens J., Clary D. O., Knusel B. Mobley W. C. (1995) Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J. Neurosci. 15, 2888 2905.
37. Liang J. Slingerland J. M. (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2, 339 345.
38. Madziar B., Lopez-Coviella I., Zemelko V. Berse B. (2005) Regulation of cholinergic gene expression by nerve growth factor depends on the phosphatidylinositol-3′-kinase pathway. J. Neurochem. 92, 767 779.
39. Manning B. D. Cantley L. C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261 1274.
40. Mellott T. J., Kowall N. W., Lopez-Coviella I. Blusztajn J. K. (2007) Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats. Brain Res. 1151, 1 11.
41. Mendez P. Garcia-Segura L. M. (2006) Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells. Endocrinology 147, 3027 3039.
42. Oosawa H., Fujii T. Kawashima K. (1999) Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells. J. Neurosci. Res. 57, 381 387.
43. Pongrac J. L. Rylett R. J. (1998) NGF-induction of the expression of ChAT mRNA in PC12 cells and primary cultures of embryonic rat basal forebrain. Brain Res. Mol. Brain Res. 62, 25 34.
44. Porstmann T., Griffiths B., Chung Y. L., Delpuech O., Griffiths J. R., Downward J. Schulze A. (2005) PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24, 6465 6481.
45. Sarbassov D. D., Guertin D. A., Ali S. M. Sabatini D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098 1101.
46. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76 85.
47. Szutowicz A., Madziar B., Pawelczyk T., Tomaszewicz M. Bielarczyk H. (2004) Effects of NGF on acetylcholine, acetyl-CoA metabolism, and viability of differentiated and non-differentiated cholinergic neuroblastoma cells. J. Neurochem. 90, 952 961.
48. Tian X., Sun X. Suszkiw J. B. (1996) Developmental age-dependent upregulation of choline acetyltransferase and vesicular acetylcholine transporter mRNA expression in neonatal rat septum by nerve growth factor. Neurosci. Lett. 209, 134 136.
49. Williams B. J., Bimonte-Nelson H. A. Granholm-Bentley A. C. (2006) ERK-mediated NGF signaling in the rat septo-hippocampal pathway diminishes with age. Psychopharmacology (Berl.) 188, 605 618.
50. Williams B., Granholm A. C. Sambamurti K. (2007) Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci. Lett. 413, 110 114.
51. Woodgett J. R. (2005) Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17, 150 157.
52. Yuen E. C., Howe C. L., Li Y., Holtzman D. M. Mobley W. C. (1996) Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev. 18, 362 368.